Clinuvel Pharmaceuticals Ltd
F:UR9A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
F:UR9A
|
AU |
|
P
|
Petrofac Ltd
F:P2F
|
JE |
|
C
|
China Resources Beer Holdings Co Ltd
XMUN:CHK
|
HK |
|
F
|
Franchetti SpA
MIL:FCH
|
IT |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
Endesa SA
F:ENA
|
ES |
|
W
|
WPP PLC
DUS:0WP
|
UK |
|
A
|
AIC Mines Ltd
XMUN:HLS
|
AU |
|
A
|
Amadeus Fire AG
DUS:AAD
|
DE |
|
G
|
Graham Holdings Co
DUS:WPOB
|
US |
|
S
|
Stainless Tankers ASA
OSE:STST
|
NO |
|
C
|
Caseys General Stores Inc
F:CS2
|
US |
|
B
|
Bank of Georgia Group PLC
XBER:GEB
|
UK |
|
Storebrand ASA
F:SKT
|
NO |
|
Baozun Inc
F:2BZ
|
CN |
|
Sterlite Technologies Ltd
NSE:STLTECH
|
IN |
|
M
|
Moody's Corp
F:DUT
|
US |
|
Heidelberger Druckmaschinen AG
F:HDD
|
DE |
|
A
|
Ansell Ltd
SWB:PD1A
|
AU |
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
Wall St Price Targets
UR9A Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for UR9A is 14.22 EUR with a low forecast of 7.55 EUR and a high forecast of 24.45 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UR9A's stock price target?
Price Target
14.22
EUR
According to Wall Street analysts, the average 1-year price target for UR9A is 14.22 EUR with a low forecast of 7.55 EUR and a high forecast of 24.45 EUR.
What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
